Skip to main content
PMC home page
Scientific Reports logoLink to Scientific Reports
. 2019 Jan 22;9:264. doi: 10.1038/s41598-018-36443-8

Comprehensive circRNA expression profile during ischemic postconditioning attenuating hepatic ischemia/reperfusion injury

Pengpeng Zhang 1, Yingzi Ming 1, Qifa Ye 1,2,✉, Ying Niu 1,✉
PMCID: PMC6342922  PMID: 30670716

Abstract

Ischemic postconditioning (IPO) attenuates hepatic ischemia/reperfusion (I/R) injury. The aim of this study was to explore the role of circular RNAs (circRNAs) in the protective mechanism of IPO. In this study, microarray hybridization analysis was performed to determine the circRNA expression profile. Briefly, a total of 1599 dysregulated circRNAs were detected. The competitive endogenous RNA (ceRNA) network, including 6 circRNAs, 47 miRNAs and 90 mRNAs, indicated that the potential “housekeeping” function of circRNAs is dysregulated in hepatic I/R injury. Based on the validation results of selected circRNAs, miRNAs and mRNAs following qRT-PCR amplification, the mmu_circRNA_005186-miR-124-3p-Epha2 pathway was constructed. Dual-luciferase reporter analysis showed that miR-124-3p interacted directly with mmu_circRNA_005186 and Epha2 through the predicted binding sites, which suggested that mmu_circRNA_005186, serving as a miRNA sponge for miR-124-3p, regulated the expression of Epha2. Functionally, we explored the mechanism of mmu_circRNA_005186 in LPS-treated RAW264.7 cells which simulated the inflammation in hepatic I/R injury. We found that mmu_circRNA_005186 silencing attenuated the LPS-induced inflammation and was associated with miR-124-3p upregulation and Epha2 downregulation. Our study is the first to show that circRNAs are closely related to hepatic I/R injury and IPO and suggests that targeting mmu_circRNA_005186-miR-124-3p-Epha2 pathway might attenuate hepatic I/R injury.

Introduction

Circular RNAs (circRNAs), a novel type of endogenous noncoding RNA that was recently rediscovered, develop covalently closed loop structures without 5′–3′ polarities1. Unlike the structure of linear RNA, which is terminated with a 5′ cap and 3′ tail, ‘backsplicing’ in which an upstream splice acceptor combines with a downstream splice donor, is the main characteristic of circRNA formation2. This special structure confers resistance against RNAase, making circRNA more stable than linear RNA and more ubiquitously expressed in tissues1. Although the function of circRNA in animals is still uncertain, the “miRNA sponge” trait of circRNA has become a popular research topic. The expression of downstream mRNA decreases when circRNA binds to its target miRNA, acting as a sponge to inhibit transcription, further influencing the pathophysiological processes of various diseases3,4.

Hepatic ischemia/reperfusion (I/R) injury is an inevitable and serious problem that occurs in clinical post-operative settings, such as after liver transplant or partial hepatectomy, that leads to pathological cellular changes and organ failure5. Jaeschke et al. verified that two obvious phases occur in acute liver injury after hepatic I/R6 and that Kupffer cells (KCs), the resident macrophages of the liver, play a pivotal role in the pathogenesis of I/R-induced acute liver injury7. Once KCs are activated, proinflammatory cytokines are produced and released, such as tumor necrosis factor α (TNF-α) and interleukin1β (IL-1β), which subsequently activates KCs to amplify the inflammatory loop and promotes neutrophil infiltration into the hepatic microcirculation8.

Currently, several mechanical and pharmacological methods have been identified that attenuate liver I/R in animal studies, and ischemic postconditioning, composed of several brief cycles of ischemia and reperfusion before the reperfusion phase, has been used to attenuate I/R injury in organs including the heart9, bowel10, kidney11, brain12 and liver13. Multiple studies have found that minimizing cell necrosis and apoptosis is crucial for the benefits of IPO14. However, no studies have reported circRNA expression profiles in hepatic I/R injury, and whether IPO can attenuate liver I/R injury by mediating circRNA expression is unknown. Therefore, in this study, considering the significance of hepatic I/R injury, we explored circRNA expression patterns via microarray hybridization and predicted the functions of the host genes of differentially expressed (DE) circRNAs. We identified an important role of circRNAs in ischemic postconditioning attenuating hepatic I/R injury.

Results

IPO attenuated liver I/R injury

To determine whether IPO can attenuate hepatic I/R injury in this animal model, H&E staining was used to evaluate the histological injury grade. The H&E staining results showed that IPO alleviated the histological injury severity of the hepatic tissue (Fig. 1).

Figure 1.

Figure 1

Open in a new tab

Representative images of hematoxylin and eosin (H&E) staining (magnification 400X, Scale Bar = 50 um). (a) Normal liver tissue and (b) hepatic ischemia-reperfusion injury liver tissue. (c) IPO improved histological injury. (d) Histological scores and hepatic injury grade. *p < 0.05, **p < 0.01.

CircRNA expression pattern during hepatic I/R injury assessed via microarray

Microarray hybridization is an efficient method for detecting differential expression profiles and biological functions of circRNAs. The results showed that a total of 1599 circRNAs were differentially expressed (p < 0.05 and fold change ≥2.0). Of these, 213 circRNAs were upregulated and 493 were down-regulated in the I/R group compared with the normal group. At the same time, 641 and 252 circRNAs were up-regulated and down-regulated, respectively, between the IPO and I/R groups (Fig. 2a,b). Hierarchical clustering analysis (heat map) was used to evaluate significantly expressed circRNAs, which were indicated by p < 0.05 and a fold change ≥2.0, among the normal, I/R and IPO groups (Fig. 2c). A Venn diagram analysis of the dysregulated circRNAs indicated that most of these RNAs (51.3% and 58.6%) were sequentially expressed (up-regulated in the I/R group and down-regulated in the IPO group) during IPO-attenuated I/R injury (Fig. 2d).

Figure 2.

Figure 2

Open in a new tab

Bioinformatic analysis of circRNA expression pattern during hepatic I/R injury by microarray. (a) Scatter plot analysis was conducted to exhibit the circRNA expression distribution. The green lines represent the default significant fold change (2.0). (b) A volcano graph was created to show significantly dysregulated circRNAs (fold change >2.0, p-value < 0.05). (c) Heat map evaluation of the distinguishable circRNA expression patterns among the normal, I/R, and IPO group samples. Each column represents the expression pattern of one sample, and high and low expression levels are indicated by the “red” and “green” lines, respectively. (d) Venn diagram analysis of dysregulated circRNAs indicated that most of them (51.3% and 58.6%) were sequentially expressed during IPO attenuation of I/R injury.

The predicted biological function of circRNA linear transcripts

To provide a comprehensive understanding of circRNAs, the linear transcripts of the corresponding origination genes for circRNAs were annotated and were further evaluated by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. The GO analysis results from the Biological Process (BP), Cellular Component (CC) and Molecular Function (MF) domains are shown. The top 10 dysregulated GO processes in each domain were analyzed and ranked according to p-value (p < 0.05). The results indicated that 1420 GO terms were dysregulated (p < 0.05) between the I/R and normal group and that 1745 terms were dysregulated between the IPO and I/R group. The top 10 GO terms from the BP, CC and MF domains in the comparison group are exhibited according to the enrichment score and are ranked by p-value; all of the top 10 GO terms for each domain were nearly identical (Fig. 3a). This result revealed that in the BP domain, the most meaningful, enriched GO terms were cellular metabolic process, primary metabolic process, metabolic process and cellular process. For the CC domain, the most meaningful, enriched GO terms were intracellular, intracellular part, cell part and cell. In addition, in MF the most meaningful, enriched GO terms were binding, protein binding and transferase activity. In addition, KEGG pathway analysis was performed, and the top 10 pathways in the compared groups were listed according to the enrichment score and were ranked by p-value (Fig. 3b). The results indicated that in the protective IPO mechanism, the role of circRNA is closely related to the mechanistic target of rapamycin (mTOR) signaling pathway and further validation are required to confirm these results.

Figure 3.

Figure 3

Open in a new tab

GO and KEGG pathway analysis of dysregulated circRNA linear transcripts. (a) GO annotation of the I/R vs N and IPO vs I/R groups via the top 10 enrichment scores in the BP, CC and MF domains. (b) KEGG pathway analysis of the I/R vs N and IPO vs I/R groups via the top 10 enrichment scores.

Validation of selected circRNAs during hepatic I/R injury by qRT-PCR

Ten sequentially expressed circRNAs among the normal, I/R and IPO groups were screened according to p-value, fold change, raw intensity and type (Table 1) in validation experiments. The results confirmed that consistent with the microarray results, mmu_circRNA_005186, mmu_circRNA_011137, mmu_circRNA_013703, mmu_circRNA_29140, mmu_circRNA_36837, and mmu_circRNA_43819 were significantly amplified by qRT-PCR (Fig. 4a).

Table 1.

Ten dys-regulated circRNAs were screened for validation by qRT-PCR.

circRNA Name Type FC* Best linear transcripts Gene Symbol P-value
up-regulated (I/R vs Normal)
mmu_circRNA_005186 exonic 3.987 NM_010139 Epha2 0.004
mmu_circRNA_44049 exonic 3.175 NM_027889 Vps11 0.007
mmu_circRNA_29064 exonic 3.126 NM_001081254 Fam186b 0.005
mmu_circRNA_32403 exonic 3.052 NM_175459 Glis3 0.003
mmu_circRNA_43819 exonic 2.148 NM_027911 Raver1 0.008
down-regulated (I/R vs Normal)
mmu_circRNA_30491 exonic 15.050 NM_001010833 Mdc1 0.028
mmu_circRNA_013703 exonic 7.142 NM_001024205 Nufip2 0.002
mmu_circRNA_29140 exonic 4.879 NM_009624 Adcy9 0.022
mmu_circRNA_011137 exonic 2.326 NM_177464 R3hcc1l 0.038
mmu_circRNA_36837 exonic 2.138 NM_009649 Akap2 0.019
Open in a new tab

*FC: Fold Change.

Figure 4.

Figure 4

Open in a new tab

Validation of selected circRNAs, miRNAs and mRNAs by qRT-PCR. (a) 6 circRNAs were significantly amplified by qRT-PCR and consistent with the microarray results. (b) 9 miRNAs were significantly amplified by qRT-PCR and were inversely correlated with their corresponding circRNAs. (c) 6 mRNAs were significantly amplified by qRT-PCR while only Epha2, Arhgap32, Heatr1 and Egr1 had an identical expression trend with their corresponding circRNAs. *p < 0.05, **p < 0.01.

Construction of the circRNA-miRNA-mRNA network and validation of predicted miRNAs and mRNAs

We predicted potential interactions among the identified circRNAs, miRNAs and target genes. A ceRNA network of circRNA-miRNA-mRNA interactions, including 6 circRNAs, 47 miRNAs and 90 mRNAs, was constructed by Cytoscape software (Fig. 5). According to the ceRNA network, circRNA, a competing endogenous RNA, increased target gene expression by removing the inhibitory effect of miRNA. 10 predicted miRNAs and mRNAs were selected from the ceRNA network to validate among the three groups by qRT-PCR, respectively. The results indicated that the expression of miR-124-3p, miR-153-3p, miR-210-5p, miR-107-3p, miR-103-3p, miR-205-5p, miR-296-5p, miR-188-3p and miR-698-5p significantly increased and were inversely correlated with their corresponding circRNAs expression (Fig. 4b). Meanwhile, qRT-PCR analysis revealed the expression of Epha2, Arhgap32, Heatr1, Stat3, IL1r1 and Egr1 were significantly different among three groups while only Epha2, Arhgap32, Heatr1 and Egr1 had an identical expression trend with their corresponding circRNAs (Fig. 4c). Based on the verified qRT-PCR data, several circRNA-miRNA-mRNA pathways were constructed, including mmu_circRNA_005186-miR-124-3p-Epha2 and mmu_circRNA_43819-miR-210-5p-Egr1. Since mmu_circRNA_005186 had a higher fold change in qRT-PCR and Epha2 was its linear gene, we therefore chose mmu_circRNA_005186-miR-124-3p-Epha2 pathway for further intensity study.

Figure 5.

Figure 5

Open in a new tab

The circRNA-miRNA-mRNA network analysis. The network consists of 6 circRNAs, 47 miRNAs and 90 mRNAs.

mmu_circRNA_005186 acted as a miRNA Sponge for miR-124-3p and regulated the expression of Epha2

To determine whether mmu_circRNA_005186 directly targets miR-124-3p through the predicted binding sites (Fig. 6a), we performed a dual-luciferase reporter assay and found that miR-124-3p mimics significantly reduced the luciferase activity of mmu_circRNA_005186-WT (p < 0.01) but not the mutant one in 293T cells (Fig. 6b). Then, we applied the dual-luciferase reporter assay to validate whether miR-124-3p interacts with Epha2 by the predicted binding sites (Fig. 6c). The results indicated that luciferase activity was significantly lower in the miR-124-3p mimic (p < 0.01) than the negative control (NC), but this reduction was not observed with the mutant plasmids (Fig. 6d). Furthermore, by qRT-PCR, we found that the expression level of miR-124-3p was significantly upregulated after mmu_circRNA_005186 silencing in RAW264.7 cells (Fig. 6e,f). In addition, the expression level of Epha2 was significantly downregulated (Fig. 6g). Collectively, the above results demonstrated that mmu_circRNA_005186 enhanced Epha2 expression level by acting as a miRNA sponge for miR-124-3p in vitro.

Figure 6.

Figure 6

Open in a new tab

mmu_circRNA_005186 acted as a miRNA Sponge for miR-124-3p and regulated the expression of Epha2. (a) Predicted binding site of miR-124-3p in mmu_circRNA_005186 and a diagram for construction of mutated reporter plasmid (mmu_circRNA_005186-Mut). (b) Dual-luciferase reporter assay showed that miR-124-3p mimics significantly repressed the luciferase activity of mmu_circRNA_005186-WT but not the mutant one in 293T cells. (c) Predicted binding site of miR-124-3p in Epha2 3′-UTR. And a diagram for construction of mutated reporter plasmid (Epha2 3′-UTR-Mut). (d) Dual-luciferase reporter assay showed that miR-124-3p mimics significantly repressed the luciferase activity of Epha2 3′-UTR-Mut but not the mutant one in 293T cells. (e) After transfection with si-005186, the expression level of mmu_circRNA_005186 was significantly inhibited in RAW264.7 cells. (f) The expression level of miR-124-3p was significantly upregulated after mmu_circRNA_005186 silencing in RAW264.7 cells. (g) The expression level of Epha2 was significantly inhibited after mmu_circRNA_005186 silencing in RAW264.7 cells. *p < 0.05, **p < 0.01.

Effect of mmu_circRNA_005186 on LPS-induced inflammation in RAW264.7 cell

Given that macrophages play a vital role in hepatic I/R injury, we sought to determine whether mmu_circRNA_005186 affects the LPS-induced inflammation in RAW264.7 cells through the mmu_circRNA_005186-miR-124-3p-Epha2 pathway. The RAW 264.7 cells were transfected with small interfering RNA against mmu_circRNA_005186 (si-005186) or si-circRNA-NC for 48 h and were stimulated by LPS. The supernatant concentrations of TNF-α and IL-1β released from RAW 264.7 cells were significantly lower in the si-005186 group than the negative control (Fig. 7a,b). As expected, qRT-PCR identified that miR-124-3p was upregulated by 6-fold (p < 0.01) (Fig. 7c) while the expression level of Epha2 markedly decreased in the si-005186 group (Fig. 7d).

Figure 7.

Figure 7

Open in a new tab

Effect of mmu_circRNA_005186 on LPS-induced inflammation in RAW264.7 cells. (a,b) ELISA assay demonstrated that the supernatant concentrations of TNF-α and IL-1β released from RAW 264.7 cells were significantly lower in the si-005186 group than the negative control. (c) qRT-PCR showed that miR-124-3p was upregulated by 6-fold in the si-005186 group. (d) mmu_circRNA_005186 silencing inhibited the expression level of Epha2 in LPS-induced inflammation. *p < 0.05, **p < 0.01.

Discussion

Currently, IPO, an effective method for attenuating hepatic I/R injury13, has been used for several years; however, the beneficial mechanism of IPO is still undefined and vague. CircRNAs, a novel type of endogenous noncoding RNA that was recently rediscovered, has gradually been recognized as a molecular biomarker15 and as a main mediator in the pathogenesis of tumor growth and metastasis16. For example, Hsa_circ_0001649 has been reported as a potential novel biomarker for hepatocellular carcinoma17. However, circRNA expression profiles in hepatic I/R injury have not been studied.

In the present study, we used microarray hybridization to detect differential expression profiles and to investigate the biological function of circRNA. A total of 1599 circRNAs were DE among the normal, I/R and IPO groups. A Venn diagram analysis indicated that the majority of the dysregulated circRNAs (51.3% and 58.6%) were sequentially expressed during IPO-induced I/R injury attenuation, which indicated that circRNA plays a vital role in I/R pathogenesis and IPO.

Increasing evidence indicates that circRNA, acts as a competing endogenous RNA or sponge, increases target gene expression by removing the inhibitory effect of miRNA4,18. For instance, miR-7a prevents myocardial ischemia-induced cell death by targeting inflammatory and apoptotic genes, however, the circRNA ciRS-7 sponges miR-7a, blocking the anti-apoptotic and cell-protective functions19. The heart-related circRNA HRCR is known to prevent cardiac hypertrophy and heart failure by sponging miR-223, which suppresses ARC expression20. In the present study, circRNA verification experiments revealed six dysregulated circRNAs following qRT-PCR amplification. To study the potential “housekeeping” functions of these identified circRNAs, a ceRNA network of circRNA-miRNA-mRNA interactions was constructed that includes 6 circRNAs, 47 miRNAs and 90 mRNAs. According to the validation results of selected miRNAs and mRNAs, several ceRNA pathways were constructed. Since the mechanism of circRNA has not been well elucidated, none of the potential circRNA-miRNA-mRNA pathways included in this study have been reported previously. The dual-luciferase analysis validated that miR-124-3p interacts directly with mmu_ circRNA_005186 and Epha2 through the predicted binding sites. The results suggest that mmu_circRNA_005186, serving as a miRNA sponge for miR-124-3p, regulated the expression of Epha2. Furthermore, we explored the mechanism of mmu_circRNA_005186 in LPS-induced RAW264.7 cells that simulated the inflammation in hepatic I/R injury. Through these functional experiments, we demonstrated that mmu_circRNA_005186 silencing attenuated the inflammation and was associated with miR-124-3p upregulation and Epha2 downregulation in vitro. Previous studies indicated that miR-124-3p commonly serves an integral roles in cell growth, apoptosis, invasion and metastasis in various cancers21–23. In addition, a recent study conducted by Shan Huang indicates that increased miR-124-3p inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons in a mouse model with traumatic brain injury24, suggesting the potential anti-inflammatory role of miR-124-3p. Furthermore, several papers reported that miR-124-3p could be useful molecular marker in brain ischemic stroke25,26. Collectively these studies confirm that consistent with our present results, miR-124-3p may inhibit inflammation and attenuate hepatic I/R injury. Epha2 belongs to the membrane-bound tyrosine kinase family, which serves as an oncogene involved in promoting the formation and progression in different types of malignancies27,28. In the present study, Epha2 is the linear gene of mmu_circRNA_005186, and this linear gene has been reported to modulate HCC radiosensitivity via p38/mitogen-activated protein kinase-mediated signaling pathways and miR-26b29. Ligand-stimulated EphA2 inhibits Akt in PTEN-deficient prostate cancer cells, glioma cells30, and other cell types31,32 and the activation of mTOR/Akt signaling pathway could protect hepatocytes from hepatic IR injury33, suggesting the potential regulating function of Epha2 in hepatic I/R injury. In addition, Saeki et al. reported that Epha2 promotes cell adhesion and spreading of monocyte and macrophage cell lines34. To the best of our knowledge, platelet and neutrophil adhesion explains the mechanism of hepatic I/R injury35. These studies provide novel insights and clues that Epha2 can be applied to study hepatic I/R injury.

In summary, our results show that 1599 circRNAs are dysregulated in hepatic I/R and IPO, and that these circRNAs might play a crucial role in these processes with potential pathophysiological functions. Moreover, we reported for the first time that mmu_circRNA_005186 exerts its function by serving as a miRNA sponge for miR-124-3p, thereby promoting the function of Epha2. Combining the preceding evidence with our functional experiments, modulation of the mmu_circRNA_005186_miR-124-3p_Epha2 pathway may be one of the possible targets and strategy to attenuate hepatic I/R injury.

Methods and Materials

Ethics approval

This research protocol was approved by the Committee on the Ethics of Animal Experiments of the Third Xiangya Hospital (No. LLSC (LA) 2016-030) and was conducted according to the Guidance for the Care and Use of Laboratory Animals of the National Institutes of Health.

Animal model

A total of eighteen 8-week-old male SPF C57BL/6 mice were provided by Hunan SLAC Laboratory Animals (Hunan, China). All mice were housed in a standard room with ad libitum water, rodent food and a 12/12 h light/dark cycle illumination for two weeks. The model of partial (70%) hepatic I/R was used in accordance with previous reports36.After an acclimatization period, the eighteen mice were randomly divided into three groups: (1) the normal (N) group, (2) the ischemia/reperfusion (I/R) group and (3) the I/R + ischemic postconditioning (IPO) group. Group N underwent laparotomy without vessel blockage; in the I/R group, liver ischemia was induced for 1 h and reperfusion for 4 h; the IPO group received three intermittent cycles of 5 seconds of ischemia, followed by 5 seconds of reperfusion before the reperfusion phase.

Cell Culture and Treatment

RAW 264.7 and 293T cells were purchased from the American Type Culture Collection (ATCC, USA) and cultured in DMEM (Gibco, USA) supplemented with 10% fetal bovine serum (HyClone, USA) according to the standard guidelines.

Si-005186 was synthesized by Geneseed Biotech (Guangzhou, China) and the si-005186 sequence is 5′- GATGCCTGCCGAGTTGTTT -3′. RAW 264.7 cells were transfected with si-005186 or si-circRNA-NC using lipofectamine 2000 (Invitrogen, USA) for 48 hours according to the manufacturer’s protocol.

RAW 264.7 cells were seeded at 2 × 106 cells in 1 ml of DMEM in 6-well plates and allowed to adhere for 12 h before stimulation by LPS (100 ng/ml, Sigma, USA). Cells were incubated with LPS for 12 h or 24 h.

Histological examination of the liver

Hematoxylin-eosin (H&E) staining was conducted to evaluate liver pathological injury. The grade of liver injury was evaluated via Suzuki’s criterion37, which indicates the severity of sinusoidal congestion, cytoplasmic vacuolation, and parenchymal cell necrosis.

Total RNA isolation and quality assessment

Total RNA was extracted from nine frozen mouse liver tissues (three randomly selected samples from each group) and cells using TRIzol (Invitrogen, USA) according to the manufacturer’s instructions. Subsequently, total RNA integrity and gDNA contamination was tested by denaturing agarose gel electrophoresis, and the concentration and quality of the total RNA samples were assessed by a NanoDrop ND-1000 instrument (NanoDrop, USA).

qRT-PCR

The cDNA synthesis and PCR amplification were carried out by a GeneAmp PCR system 9700 (Applied Biosystems, USA) and ViiA 7 real-time PCR system (Applied Biosystems, USA), respectively. RNA expression was defined as the threshold cycle (Ct). GAPDH was amplified as the internal control for circRNAs and mRNAs and U6 was amplified as the internal control for miRNAs. The relative expression levels were calculated by the double-standard curve method. All primers (Supplementary Table S1) were designed and synthesized by Kangchen Bio-tech (Shanghai, China).

RNA labelling and circRNA microarray hybridization

RNA labelling and array hybridization were performed according to the manufacturer’s protocol. The enriched circRNAs were amplified and transcribed into fluorescent cRNA. The labeled cRNAs were purified by a RNeasy Mini Kit (Qiagen). The concentration and specific activity of the labelled cRNAs (pmol Cy3/μg cRNA) were measured by a NanoDrop ND-1000 instrument. Each labelled cRNA (1 μg) was fragmented by the addition of 5 μl of 10× blocking agent and 1 μl of 25× fragmentation buffer; then, the mixture was heated at 60 °C for 30 min, and finally, 25 μl of 2× hybridization buffer was added to dilute the labeled cRNA. Hybridization solution (50 μl) was dispensed onto the gasket slide, and this slide was placed onto the circRNA expression microarray slide. The hybridized arrays were washed, fixed and scanned using an Agilent Scanner G2505C.

CircRNA expression profile data analysis

Agilent Feature Extraction software (version 11.0.1.1) was used to analyse acquired array images. When the data were extracted, quantile normalization and subsequent data processing were conducted using the R software Limma package. CircRNAs that were significantly DE between the two groups were identified through fold change and p-values (fold change ≥2.0 and p-value < 0.05). The log2 ratio was used for quantile normalization. Hierarchical clustering was conducted to show distinguishable circRNA expression profiles among the samples. Significantly DE circRNAs among the three groups were identified through volcano plot filtering.

Annotation of linear transcripts and GO and KEGG pathway analysis of host genes

Linear transcripts overlapping with the chromosome location of the circRNA sequence were annotated. CircRNA distribution in the genome was determined by comparing the circRNA with genetic elements. GO analysis was used to investigate three domains of functionality: BP, CC and MF. Fisher’s exact test in the Bioconductor topGO package was used to determine if more overlap existed between the DE list and the GO annotation list than would be expected by chance. The p-value produced by the topGO analysis denotes the significance of the GO term enrichment in the DE genes (p < 0.05). Pathway analysis was performed to functionally analyze and map genes to KEGG pathways. The p-value denotes the significance of the pathway correlated with the conditions (p < 0.05).

Validation of selected circRNAs, miRNAs and mRNAs

Ten circRNAs were selected on the basis of a combination of p-value, fold change, raw intensity and type. Ten miRNAs and mRNAs were selected according to the ceRNA network. In addition, further qRT-PCR validation was performed by a SYBR Green PCR kit (Arraystar, USA) in triplicate for each sample.

Prediction of miRNAs and mRNAs related to circRNAs and construction of the circRNA-miRNA-mRNA Network

To identify predicted circRNA and miRNA interactions, Arraystar’s in-house miRNA target prediction software was applied on the basis of TargetScan and miRanda algorithms. To improve prediction reliability, we set the context + score to less than −0.5. Then, the potential miRNA targets were predicted with miRanda and TargetScan databases, and the ceRNA network of circRNA-miRNA-mRNA was delineated using Cytoscape software.

Luciferase reporter assay

The sequence of mmu_circRNA_005186 or the 3′-UTR of the Epha2 mRNA, including the seed sequence of the miR-124-3p binding site and a mutated binding site, was cloned into the pmirGLO dual-luciferase vector (Promega, USA).Then, 293T cells were co-transfected with miRNA-124-3p mimics and luciferase vectors using lipofectamine 2000 (Invitrogen, USA). After incubation for 48 h, firefly and Renilla luciferase activity was measured using the DualGlo luciferase assay system (Promega) according to the standard protocol.

ELISA assay for TNF-α and IL-1β

After treatment with LPS (100 ng/ml) for 24 h, the supernatant concentrations of TNF-α and IL-1β released from RAW 264.7 cells were measured by an automated microplate reader (Heales, China) using commercial ELISA kits according to the instructions of the kits (Abcam, USA).

Statistical analysis

The microarray data are reported as the means ± SEM. All other statistical data were analyzed and visualized by GraphPad Prism 5.0 and Student’s t-test. The p-values were used to evaluate statistical significance (p < 0.05).

Electronic supplementary material

Supplementary Table S1 (92.2KB, pdf)

Acknowledgements

The work was supported by the National Natural Science Foundation of China (grant number U1403222). We would like to thank Kangchen Bio-tech for their technical support with the microarray assays.

Author Contributions

Q.Y. and Y.M. conceptualized the project. Y.N. and P.Z carried out the animal experiments and analyzed data. P.Z. drafted the manuscript. All authors revised and approved final version of the manuscript.

Data Availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request or GEO database (GSE117524).

Competing Interests

The authors declare no competing interests.

Footnotes

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Qifa Ye, Email: yqf_china@126.com.

Ying Niu, Email: niuying1@aliyun.com.

Electronic supplementary material

Supplementary information accompanies this paper at 10.1038/s41598-018-36443-8.

References

  • 1.Qu S, et al. Circular RNA: a new star of noncoding RNAs. Cancer letters. 2015;365:141–148. doi: 10.1016/j.canlet.2015.06.003. [DOI] [PubMed] [Google Scholar]
  • 2.Memczak S, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333–338. doi: 10.1038/nature11928. [DOI] [PubMed] [Google Scholar]
  • 3.Wilusz JE, Sharp PA. A circuitous route to noncoding RNA. Science. 2013;340:440–441. doi: 10.1126/science.1238522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Sen, R., Ghosal, S., Das, S., Balti, S. & Chakrabarti, J. Competing endogenousRNA: the key to posttranscriptional regulation. The Scientific World Journal 2014 (2014). [DOI] [PMC free article] [PubMed]
  • 5.Boros P, Bromberg J. New cellular and molecular immune pathways in ischemia/reperfusion injury. American Journal of Transplantation. 2006;6:652–658. doi: 10.1111/j.1600-6143.2005.01228.x. [DOI] [PubMed] [Google Scholar]
  • 6.Jaeschke H, Bautista AP, Spolarics Z, Spitzer JJ. Superoxide generation by Kupffer cells and priming of neutrophils during reperfusion after hepatic ischemia. Free radical research communications. 1991;15:277–284. doi: 10.3109/10715769109105223. [DOI] [PubMed] [Google Scholar]
  • 7.Akai S, Uematsu Y, Tsuneyama K, Oda S, Yokoi T. Kupffer cell‐mediated exacerbation of methimazole‐induced acute liver injury in rats. Journal of Applied Toxicology. 2016;36:702–715. doi: 10.1002/jat.3202. [DOI] [PubMed] [Google Scholar]
  • 8.Feng M, Wang Q, Zhang F, Lu L. Ex vivo induced regulatory T cells regulate inflammatory response of Kupffer cells by TGF-beta and attenuate liver ischemia reperfusion injury. International immunopharmacology. 2012;12:189–196. doi: 10.1016/j.intimp.2011.11.010. [DOI] [PubMed] [Google Scholar]
  • 9.Penna C, et al. Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats. Basic research in cardiology. 2010;105:181–192. doi: 10.1007/s00395-009-0075-6. [DOI] [PubMed] [Google Scholar]
  • 10.Santos CHMD, Gomes OM, Pontes JCDV, Miiji LNO, Bispo MAF. The ischemic preconditioning and postconditioning effect on the intestinal mucosa of rats undergoing mesenteric ischemia/reperfusion procedure. Acta Cirurgica Brasileira. 2008;23:22–28. doi: 10.1590/S0102-86502008000100005. [DOI] [PubMed] [Google Scholar]
  • 11.Chen H, et al. Ischemic postconditioning inhibits apoptosis after renal ischemia/reperfusion injury in rat. Transplant International. 2008;21:364–371. doi: 10.1111/j.1432-2277.2007.00606.x. [DOI] [PubMed] [Google Scholar]
  • 12.Rehni AK, Singh N. Role of phosphoinositide 3-kinase in ischemic postconditioning-induced attenuation of cerebral ischemia-evoked behavioral deficits in mice. Pharmacological reports. 2007;59:192. [PubMed] [Google Scholar]
  • 13.Santos CHM. d. et al. Postconditioning effect in the hepatic ischemia and reperfusion in rats. Acta cirurgica brasileira. 2010;25:163–168. doi: 10.1590/S0102-86502010000200008. [DOI] [PubMed] [Google Scholar]
  • 14.Yoon S-Y, Kim CY, Han HJ, Lee KO, Song T-J. Protective effect of ischemic postconditioning against hepatic ischemic reperfusion injury in rat liver. Annals of surgical treatment and research. 2015;88:241–245. doi: 10.4174/astr.2015.88.5.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zhu X, et al. hsa_circ_0013958: a circular RNA and potential novel biomarker for lung adenocarcinoma. The FEBS Journal. 2017;284:2170–2182. doi: 10.1111/febs.14132. [DOI] [PubMed] [Google Scholar]
  • 16.Hsiao K-Y, et al. Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Cancer research. 2017;77:2339–2350. doi: 10.1158/0008-5472.CAN-16-1883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Qin M, et al. Hsa_circ_0001649: a circular RNA and potential novel biomarker for hepatocellular carcinoma. Cancer Biomarkers. 2016;16:161–169. doi: 10.3233/CBM-150552. [DOI] [PubMed] [Google Scholar]
  • 18.Zhang, L. et al. CircRNA-9119 regulates the expression of prostaglandin-endoperoxide synthase 2 (PTGS2) by sponging miR-26a in the endometrial epithelial cells of dairy goat. Reproduction, Fertility and Development (2018). [DOI] [PubMed]
  • 19.Zheng X, Zhang M, Xu M. Detection and characterization of ciRS-7: a potential promoter of the development of cancer. Neoplasma. 2017;64:321–328. doi: 10.4149/neo_2017_301. [DOI] [PubMed] [Google Scholar]
  • 20.Wang K, et al. A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223. European heart journal. 2016;37:2602–2611. doi: 10.1093/eurheartj/ehv713. [DOI] [PubMed] [Google Scholar]
  • 21.Li L, et al. Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Molecular cancer. 2013;12:163. doi: 10.1186/1476-4598-12-163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Xie L, et al. MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer. Molecular and cellular biochemistry. 2014;392:153–159. doi: 10.1007/s11010-014-2028-0. [DOI] [PubMed] [Google Scholar]
  • 23.Zheng F, et al. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut, gut. 2011;2011:239145. doi: 10.1136/gut.2011.239145. [DOI] [PubMed] [Google Scholar]
  • 24.Huang S, et al. Increased miR-124-3p in microglial exosomes following traumatic brain injury inhibits neuronal inflammation and contributes to neurite outgrowth via their transfer into neurons. The FASEB Journal. 2017;32:512–528. doi: 10.1096/fj.201700673R. [DOI] [PubMed] [Google Scholar]
  • 25.Leung LY, et al. Comparison of miR-124-3p and miR-16 for early diagnosis of hemorrhagic and ischemic stroke. Clinica Chimica Acta. 2014;433:139–144. doi: 10.1016/j.cca.2014.03.007. [DOI] [PubMed] [Google Scholar]
  • 26.Rainer TH, et al. Plasma miR-124-3p and miR-16 concentrations as prognostic markers in acute stroke. Clinical biochemistry. 2016;49:663–668. doi: 10.1016/j.clinbiochem.2016.02.016. [DOI] [PubMed] [Google Scholar]
  • 27.Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nature Reviews Cancer. 2010;10:165. doi: 10.1038/nrc2806. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ireton RC, Chen J. EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics. Current cancer drug targets. 2005;5:149–157. doi: 10.2174/1568009053765780. [DOI] [PubMed] [Google Scholar]
  • 29.Jin Q, Li XJ, Cao P. G. miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2. Iranian journal of basic medical sciences. 2016;19:851. [PMC free article] [PubMed] [Google Scholar]
  • 30.Miao H, et al. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer cell. 2009;16:9–20. doi: 10.1016/j.ccr.2009.04.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Yang N-Y, et al. Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells. Cellular signalling. 2011;23:201–212. doi: 10.1016/j.cellsig.2010.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lin B, Yin T, Wu YI, Inoue T, Levchenko A. Interplay between chemotaxis and contact inhibition of locomotion determines exploratory cell migration. Nature communications. 2015;6:6619. doi: 10.1038/ncomms7619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zhu J, et al. Rapamycin protection of livers from ischemia and reperfusion injury is dependent on both autophagy induction and mammalian target of rapamycin complex 2-Akt activation. Transplantation. 2015;99:48–55. doi: 10.1097/TP.0000000000000476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Saeki N, Nishino S, Shimizu T, Ogawa K. EphA2 promotes cell adhesion and spreading of monocyte and monocyte/macrophage cell lines on integrin ligand-coated surfaces. Cell adhesion & migration. 2015;9:469–482. doi: 10.1080/19336918.2015.1107693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology. 2000;32:169–173. doi: 10.1053/jhep.2000.9323. [DOI] [PubMed] [Google Scholar]
  • 36.Kuboki S, et al. Peroxisome proliferator‐activated receptor‐γ protects against hepatic ischemia/reperfusion injury in mice. Hepatology. 2008;47:215–224. doi: 10.1002/hep.21963. [DOI] [PubMed] [Google Scholar]
  • 37.Ke B, et al. HO-1–STAT3 axis in mouse liver ischemia/reperfusion injury: Regulation of TLR4 innate responses through PI3K/PTEN signaling. Journal of hepatology. 2012;56:359–366. doi: 10.1016/j.jhep.2011.05.023. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Table S1 (92.2KB, pdf)

Data Availability Statement

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request or GEO database (GSE117524).

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES